Overview
Katy Tsai is a Hematologist and an Oncologist in San Francisco, California. Dr. Tsai is rated as an Experienced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. Her top areas of expertise are Melanoma, Melanoma of the Eye, Merkel Cell Carcinoma, and Uveal Melanoma.
Her clinical research consists of co-authoring 52 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
400 Parnassus Ave, San Francisco, CA 94143
2330 Post St, San Francisco, CA 94115
Additional Areas of Focus
Dr. Tsai has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
University Of California San Francisco
Alain Algazi is a Hematologist Oncology specialist and a Hematologist in San Francisco, California. Dr. Algazi is rated as an Elite provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Melanoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Polymorphous Low Grade Adenocarcinoma, and Glioma.
Stanford Health Care
Saad Khan is an Oncologist and a Hematologist in Stanford, California. Dr. Khan is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Olfactory Neuroblastoma, Teratocarcinosarcoma, Anaplastic Thyroid Cancer, and Thyroid Cancer.
Stanford Health Care
Alexander Colevas is an Oncologist and a Hematologist Oncology provider in Stanford, California. Dr. Colevas is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Nasopharyngeal Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), Oral Squamous Cell Carcinoma, and Thyroid Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- MelanomaDr. Tsai isElite. Learn about Melanoma.
- Distinguished
- Melanoma of the EyeDr. Tsai isDistinguished. Learn about Melanoma of the Eye.
- Merkel Cell CarcinomaDr. Tsai isDistinguished. Learn about Merkel Cell Carcinoma.
- Advanced
- Metastatic Uveal MelanomaDr. Tsai isAdvanced. Learn about Metastatic Uveal Melanoma.
- Neuroendocrine TumorDr. Tsai isAdvanced. Learn about Neuroendocrine Tumor.
- Uveal MelanomaDr. Tsai isAdvanced. Learn about Uveal Melanoma.
- Experienced
- Anal CancerDr. Tsai isExperienced. Learn about Anal Cancer.
- Basal Cell Skin CancerDr. Tsai isExperienced. Learn about Basal Cell Skin Cancer.
- Bone TumorDr. Tsai isExperienced. Learn about Bone Tumor.
- Brain TumorDr. Tsai isExperienced. Learn about Brain Tumor.
- Eccrine PorocarcinomaDr. Tsai isExperienced. Learn about Eccrine Porocarcinoma.
- GliomaDr. Tsai isExperienced. Learn about Glioma.
